Alimera’s Alaway Follows Novartis’ Zaditor To Spring 2007 OTC Launch
This article was originally published in The Tan Sheet
Executive Summary
Alimera Sciences plans to launch its Alaway over-the-counter ophthalmic solution at the same time as its bioequivalent competitor, Novartis' Zaditor.